These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 3112102

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model.
    Zuravleff JJ, Chervenick P, Yu VL, Muder RR, Diven WF.
    J Lab Clin Med; 1984 Jun; 103(6):878-85. PubMed ID: 6427375
    [Abstract] [Full Text] [Related]

  • 23. Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
    Johnson DE, Calia FM, Snyder MJ, Warren JW, Schimpff SC.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():89-96. PubMed ID: 6583199
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ceftazidime versus a combination of amikacin and ticarcillin in the treatment of severe infections.
    Limson BM, Navarro-Almario E, Litam P, Que E, Kua LT.
    Clin Ther; 1988 Dec; 10(5):589-93. PubMed ID: 2856601
    [Abstract] [Full Text] [Related]

  • 26. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP, Pico JL, Chiche D, Fitoussi F, Delmer A, Baume D, Rio B, Ajchenbaum F, Richet H, Tancrède C.
    Presse Med; 1988 Oct 26; 17(37):1968-70. PubMed ID: 2973598
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Pefanis A, Giamarellou H, Karayiannakos P, Donta I.
    Antimicrob Agents Chemother; 1993 Feb 26; 37(2):308-13. PubMed ID: 8452362
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model.
    Gerber AU, Stritzko T, Segessenmann C, Stalder B.
    Scand J Infect Dis Suppl; 1990 Feb 26; 74():195-203. PubMed ID: 2151488
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical characteristics and antibiotic treatment of peritoneal dialysis-associated peritonitis caused by Pseudomonas species: a review of 15 years' experience from southern China.
    Dong X, Xie C, Yi C, Ye P, Ye H, Guo Q, Huang F, Kong Y-Z, Yang X.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0009624. PubMed ID: 38695572
    [Abstract] [Full Text] [Related]

  • 35. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Gold R, Overmeyer A, Knie B, Fleming PC, Levison H.
    Pediatr Infect Dis; 1985 Jun 04; 4(2):172-7. PubMed ID: 3885181
    [Abstract] [Full Text] [Related]

  • 36. Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
    Verghese A, Berk SL.
    Am J Med; 1983 Jun 04; 74(6):1092. PubMed ID: 6222648
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study.
    Kosmidis H, Varvoutsi M, Kafetzis D, Koupari G, Bouhoutsou D, Papadatos C.
    Chemioterapia; 1987 Jun 04; 6(2 Suppl):396-8. PubMed ID: 3334581
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
    Lumish RM, Norden CW.
    J Infect Dis; 1976 May 04; 133(5):538-47. PubMed ID: 816976
    [Abstract] [Full Text] [Related]

  • 40. Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    Chadwick EG, Shulman ST, Yogev R.
    J Infect Dis; 1986 Oct 04; 154(4):670-5. PubMed ID: 3528320
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.